Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
1.010
-0.200 (-16.53%)
At close: Nov 20, 2024, 4:00 PM
1.040
+0.030 (2.97%)
Pre-market: Nov 21, 2024, 6:19 AM EST

Jin Medical International Revenue

Jin Medical International had revenue of $10.56M in the half year ending March 31, 2024, with 11.51% growth. This brings the company's revenue in the last twelve months to $20.13M, up 0.75% year-over-year. In the fiscal year ending September 30, 2023, Jin Medical International had annual revenue of $19.82M with 3.29% growth.

Revenue (ttm)
$20.13M
Revenue Growth
+0.75%
P/S Ratio
7.82
Revenue / Employee
$82,144
Employees
245
Market Cap
158.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202319.82M630.92K3.29%
Sep 30, 202219.19M-1.57M-7.58%
Sep 30, 202120.76M4.57M28.22%
Sep 30, 202016.19M-4.17M-20.49%
Sep 30, 201920.37M-545.02K-2.61%
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 444.20M
Heron Therapeutics 137.74M
InfuSystem Holdings 132.78M
Nektar Therapeutics 93.14M
Sight Sciences 79.54M
Nanobiotix 45.22M
Cellectis 36.04M
Senseonics Holdings 22.21M
Revenue Rankings